Xilio Therapeutics, Inc. (XLO)
NASDAQ: XLO · Real-Time Price · USD
0.941
-0.079 (-7.73%)
Nov 20, 2024, 4:00 PM EST - Market closed
Xilio Therapeutics Market Cap
Xilio Therapeutics has a market cap or net worth of $41.37 million as of November 21, 2024. Its market cap has decreased by -21.30% in one year.
Market Cap
41.37M
Enterprise Value
-11.48M
1-Year Change
-21.30%
Ranking
Category
Stock Price
$0.94
Market Cap Chart
Since the IPO on October 22, 2021, Xilio Therapeutics's market cap has decreased from $426.71M to $41.37M, a decrease of -90.31%. That is a compound annual growth rate of -53.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 41.37M | 173.22% |
| Dec 29, 2023 | 15.14M | -79.46% |
| Dec 30, 2022 | 73.73M | -83.14% |
| Dec 31, 2021 | 437.33M | 2.49% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Actinium Pharmaceuticals | 43.36M |
| Fortress Biotech | 43.27M |
| Affimed | 42.65M |
| Gain Therapeutics | 42.39M |
| VYNE Therapeutics | 41.60M |
| Rallybio | 41.24M |
| NeueHealth | 40.85M |
| iCAD, Inc. | 40.72M |